Preparation of amifostine polylactide-co-glycolide microspheres and its irradiation protective to mouse through oral

Ting-Li Lu1, Wei-guang Sun, Wen Zhao

  • 1Key Laboratory for Space Biosciences & Biotechnology, Faculty of Life Science, Northwestern Polytechnical University, Xi'an, China. lutinglixinxin@nwpu.edu.cn

Insights

This study developed amifostine-loaded polylactide-co-glycolide (PLGA) microspheres for oral administration. The amifostine PLGA microspheres demonstrated superior radioprotective effects in mice compared to free amifostine.

Area of Science:

  • Biomedical Engineering
  • Radiopharmacology
  • Drug Delivery Systems

Background:

  • Amifostine is a radioprotective agent.
  • Developing effective oral delivery systems for amifostine is crucial for radiation protection.
  • Polylactide-co-glycolide (PLGA) microspheres offer potential for sustained drug release.

Purpose of the Study:

  • To prepare amifostine-loaded PLGA microspheres.
  • To evaluate the in vitro release characteristics of amifostine from PLGA microspheres.
  • To investigate the in vivo radioprotective efficacy of oral amifostine PLGA microspheres in mice.

Main Methods:

  • Amifostine-loaded PLGA microspheres were formulated using a modified double emulsion-solvent evaporation technique.
  • In vitro drug release was assessed using a dialysis method in phosphate-buffered saline at 37°C.
  • In vivo radioprotection was evaluated in mice exposed to cobalt-60 gamma radiation, monitoring blood cell counts, SOD activity, and MDA levels.

Main Results:

  • The PLGA microspheres were spherical with a mean diameter of 2.8 ± 0.1 μm.
  • Amifostine release exhibited a biphasic profile: a 50% burst effect in 6 hours, followed by sustained release (80% in 48 hours, ~100% in 144 hours).
  • Amifostine PLGA microspheres showed significantly better radioprotective effects than free amifostine in mice.

Conclusions:

  • Amifostine-loaded PLGA microspheres can be effectively prepared using the described method.
  • The PLGA microspheres provide sustained release of amifostine, suitable for oral administration.
  • Oral administration of amifostine PLGA microspheres offers enhanced radioprotection in mice compared to free amifostine.

Related Concept Videos